65 related articles for article (PubMed ID: 16860375)
1. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS.
Zhu J; Choi WS; McCoy JG; Negri A; Zhu J; Naini S; Li J; Shen M; Huang W; Bougie D; Rasmussen M; Aster R; Thomas CJ; Filizola M; Springer TA; Coller BS
Sci Transl Med; 2012 Mar; 4(125):125ra32. PubMed ID: 22422993
[TBL] [Abstract][Full Text] [Related]
3. Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.
Basani RB; Zhu H; Thornton MA; Soto CS; Degrado WF; Kowalska MA; Bennett JS; Poncz M
Blood; 2009 Jan; 113(4):902-10. PubMed ID: 18987357
[TBL] [Abstract][Full Text] [Related]
4. Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets.
Kouki A; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tselepis AD; Tsikaris V; Tsoukatos DC
J Thromb Haemost; 2005 Oct; 3(10):2324-30. PubMed ID: 16129021
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of transient shear stress on platelet activation, adhesion, and aggregation with microfluidic chip technique.
Gao X; Zhang T; Huang X; Huan X; Li Y
Artif Organs; 2024 Jan; 48(1):28-36. PubMed ID: 37792630
[TBL] [Abstract][Full Text] [Related]
6. High glucose removes natural anti-α-galactoside and anti-β-glucoside antibody immune complexes adhering to surface O-glycoproteins of normal platelets and enhances platelet aggregation.
Karthi S; Sukumari-Ramesh S; Geetha M; Appukuttan PS
Exp Ther Med; 2022 Jan; 23(1):82. PubMed ID: 34934451
[TBL] [Abstract][Full Text] [Related]
7. Carbamylation of Integrin
Binder V; Chruścicka-Smaga B; Bergum B; Jaisson S; Gillery P; Sivertsen J; Hervig T; Kaminska M; Tilvawala R; Nemmara VV; Thompson PR; Potempa J; Marti HP; Mydel P
J Am Soc Nephrol; 2022 Oct; 33(10):1841-1856. PubMed ID: 36038265
[TBL] [Abstract][Full Text] [Related]
8. Role of the fibrinogen gamma-chain sequence gamma316-322 in platelet-mediated clot retraction.
Remijn JA; IJsseldijk MJ; De Groot PG
J Thromb Haemost; 2003 Oct; 1(10):2245-6. PubMed ID: 14521614
[No Abstract] [Full Text] [Related]
9. Potential Mechanism of Platelet GPIIb/IIIa and Fibrinogen on Retinal Vein Occlusion.
Ren H; Sun Y; Li Y; Yuan X; Jiang B; Zhang W; Liu G; Lu P
Curr Eye Res; 2024 Mar; ():1-11. PubMed ID: 38482878
[TBL] [Abstract][Full Text] [Related]
10. Factor H binds to washed human platelets.
Vaziri-Sani F; Hellwage J; Zipfel PF; Sjöholm AG; Iancu R; Karpman D
J Thromb Haemost; 2005 Jan; 3(1):154-62. PubMed ID: 15634279
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen and prothrombin binding is enhanced to the Pro33 isoform of purified integrin alphaIIbbeta3.
Vijayan KV; Liu Y; Souza S; Thiagarajan P; Bray PF
J Thromb Haemost; 2006 Apr; 4(4):905-6. PubMed ID: 16634766
[No Abstract] [Full Text] [Related]
12. Response of human blood platelets to preparations from leaves of Paulownia Clon in Vitro 112.
Sławińska N; Rolnik A; Stochmal A; Olas B
Biomed Pharmacother; 2023 Sep; 165():115220. PubMed ID: 37499458
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Mechanism of Platelet Aggregation Suppression by Thioterpenoids: Molecular Docking and In Vivo Antiaggregant Activity.
Nikitina LE; Bocharov PS; Ksenofontov AA; Antina EV; Gilfanov IR; Pavelyev RS; Ostolopovskaya OV; Fedyunina IV; Azizova ZR; Pestova SV; Izmest'ev ES; Rubtsova SA; Boichuk SV; Galembikova AR; Smolyarchuk EA; Mustafin IG; Kayumov AR; Samorodov AV
Biomimetics (Basel); 2023 Nov; 8(8):. PubMed ID: 38132509
[TBL] [Abstract][Full Text] [Related]
14. Ontogenesis of functional platelet subpopulations from preterm and term neonates to adulthood: The PLINIUS study.
Weiss LJ; Drayss M; Mott K; Beck S; Unsin D; Just B; Speer CP; Härtel C; Andres O; Schulze H
Blood Adv; 2023 Aug; 7(16):4334-4348. PubMed ID: 37042931
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-IV polymorphisms Q360H and T347S attenuate its endogenous inhibition of thrombosis.
MacKeigan DT; Yu SY; Chazot N; Zhang D; Khoury CJ; Lei X; Bhoria P; Shen C; Chen P; Zhu G; Rand ML; Heximer S; Ni H
Biochem Biophys Res Commun; 2024 Jun; 712-713():149946. PubMed ID: 38643717
[TBL] [Abstract][Full Text] [Related]
16. FcRgamma-chain-dependent alphaIIbeta3 elicited outside-in signaling.
Liu J; Ware J; Jackson CW; Gartner TK
J Thromb Haemost; 2007 Feb; 5(2):426-8. PubMed ID: 17105578
[No Abstract] [Full Text] [Related]
17. Intravenous hemostats: challenges in translation to patients.
Lashof-Sullivan M; Shoffstall A; Lavik E
Nanoscale; 2013 Nov; 5(22):10719-28. PubMed ID: 24088870
[TBL] [Abstract][Full Text] [Related]
18. In search of a better platelet ADP-receptor blocker.
Verheugt FW
Neth Heart J; 2009 May; 17(5):188-9. PubMed ID: 19484153
[No Abstract] [Full Text] [Related]
19. Lipoprotein(a): an important consideration for DAPT therapy after PCI.
Cui K; Dou K
Cardiol J; 2024; 31(2):365-366. PubMed ID: 38686991
[No Abstract] [Full Text] [Related]
20. Lipoprotein(a), platelet function and cardiovascular disease.
Bhatia HS; Becker RC; Leibundgut G; Patel M; Lacaze P; Tonkin A; Narula J; Tsimikas S
Nat Rev Cardiol; 2024 May; 21(5):299-311. PubMed ID: 37938756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
